Bora Pharmaceuticals Co., Ltd. (TPE:6472)
Taiwan · Delayed Price · Currency is TWD 384.00
+6.00 (1.59%)
Jul 30, 2026, 1:30 PM CST
Bora Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,832 | 5,077 | 5,829 | 3,053 | 3,281 | 910.75 |
Short-Term Investments | 38.54 | 38.37 | 67.86 | 342.63 | 247.62 | - |
Trading Asset Securities | 17.1 | 20.28 | 20.28 | - | - | - |
Cash & Short-Term Investments | 4,888 | 5,136 | 5,917 | 3,396 | 3,529 | 910.75 |
Cash Growth | -5.73% | -13.21% | 74.25% | -3.77% | 287.48% | 35.94% |
Accounts Receivable | 9,511 | 9,260 | 10,482 | 4,028 | 6,120 | 824.77 |
Other Receivables | 449.67 | 344.91 | 766.08 | 82.61 | 286.38 | 33.23 |
Receivables | 9,961 | 9,604 | 11,248 | 4,111 | 6,407 | 858.01 |
Inventory | 3,710 | 3,410 | 5,502 | 2,157 | 1,991 | 928.64 |
Prepaid Expenses | 783.58 | 675.46 | 591 | 801.43 | 242.47 | 63.07 |
Other Current Assets | 469.87 | 511.69 | 118.63 | 138.63 | 71.58 | 31.87 |
Total Current Assets | 19,812 | 19,338 | 23,377 | 10,604 | 12,241 | 2,792 |
Property, Plant & Equipment | 11,345 | 11,183 | 12,510 | 7,494 | 7,300 | 4,067 |
Long-Term Investments | 5,846 | 5,929 | 236.33 | 21.26 | 62.03 | - |
Goodwill | 2,675 | 2,664 | 3,618 | 3,010 | 983.59 | - |
Other Intangible Assets | 3,531 | 3,580 | 3,920 | 2,665 | 1,164 | 171.05 |
Long-Term Deferred Tax Assets | 1,114 | 1,170 | 1,190 | 1,045 | 829.64 | 243.78 |
Other Long-Term Assets | 1,009 | 849.81 | 657.62 | 294.85 | 181.01 | 98.65 |
Total Assets | 45,332 | 44,714 | 45,510 | 25,134 | 22,761 | 7,372 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 938.4 | 925.1 | 792.34 | 380.45 | 454.74 | 235.81 |
Accrued Expenses | 138.93 | 130.72 | 252.47 | 30.86 | 29.33 | 321.24 |
Short-Term Debt | 3,410 | 3,950 | 2,598 | 767.51 | 2,161 | 645.48 |
Current Portion of Long-Term Debt | 1,047 | 1,691 | 1,189 | 630.5 | 725.63 | 222.09 |
Current Portion of Leases | 106.77 | 80.62 | 116.6 | 106.04 | 75.31 | 17.54 |
Current Income Taxes Payable | 432.32 | 321.05 | 484.33 | 987.43 | 238.65 | 50.58 |
Current Unearned Revenue | 306.71 | 262.52 | 245.6 | 224.6 | 85.69 | 20.47 |
Other Current Liabilities | 7,958 | 5,960 | 8,130 | 5,102 | 6,725 | 327.91 |
Total Current Liabilities | 14,338 | 13,321 | 13,808 | 8,229 | 10,496 | 1,841 |
Long-Term Debt | 12,319 | 11,796 | 14,324 | 2,724 | 4,037 | 1,028 |
Long-Term Leases | 663.56 | 708.9 | 745.96 | 763.33 | 596.88 | 305.97 |
Long-Term Unearned Revenue | 21.73 | 88.87 | - | - | 4.18 | - |
Pension & Post-Retirement Benefits | 120.81 | 99.39 | 129.04 | 115.36 | 136.41 | 136.28 |
Long-Term Deferred Tax Liabilities | 1,035 | 988.55 | 1,256 | 783.9 | 742.85 | 609.77 |
Other Long-Term Liabilities | 204.75 | 239.08 | 323.59 | 753.09 | 1,608 | 298.57 |
Total Liabilities | 28,703 | 27,242 | 30,586 | 13,368 | 17,621 | 4,220 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,277 | 1,274 | 1,031 | 1,014 | 753.82 | 684.12 |
Additional Paid-In Capital | 6,262 | 6,056 | 4,408 | 3,318 | 1,236 | 1,026 |
Retained Earnings | 7,099 | 8,346 | 7,020 | 4,729 | 2,549 | 1,466 |
Treasury Stock | -133.67 | -134.29 | -43.18 | -50.97 | -53.09 | - |
Comprehensive Income & Other | 64.65 | -159.75 | 362.83 | 74.66 | 42.2 | -23.26 |
Total Common Equity | 14,569 | 15,381 | 12,779 | 9,085 | 4,528 | 3,153 |
Minority Interest | 2,060 | 2,091 | 2,144 | 2,681 | 612.13 | - |
Shareholders' Equity | 16,629 | 17,472 | 14,923 | 11,766 | 5,140 | 3,153 |
Total Liabilities & Equity | 45,332 | 44,714 | 45,510 | 25,134 | 22,761 | 7,372 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17,547 | 18,227 | 18,973 | 4,991 | 7,596 | 2,219 |
Net Cash (Debt) | -12,659 | -13,091 | -13,056 | -1,595 | -4,067 | -1,308 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -67.51 | -69.41 | -92.49 | -12.84 | -34.34 | -11.20 |
Filing Date Shares Outstanding | 127.36 | 126.99 | 123.39 | 121.33 | 117.01 | 117.32 |
Total Common Shares Outstanding | 127.36 | 126.99 | 123.39 | 121.33 | 117.01 | 117.32 |
Working Capital | 5,475 | 6,017 | 9,569 | 2,375 | 1,745 | 951.22 |
Book Value Per Share | 114.39 | 121.12 | 103.57 | 74.88 | 38.70 | 26.87 |
Tangible Book Value | 8,363 | 9,137 | 5,241 | 3,410 | 2,381 | 2,981 |
Tangible Book Value Per Share | 65.67 | 71.95 | 42.47 | 28.10 | 20.35 | 25.41 |
Land | 3,765 | 3,758 | 3,824 | 3,424 | 3,397 | 1,984 |
Buildings | 7,396 | 7,289 | 7,963 | 1,945 | 1,905 | 1,393 |
Machinery | 4,219 | 3,870 | 6,113 | 2,814 | 2,390 | 859.79 |
Construction In Progress | 892.2 | 809.38 | 527.38 | 115.84 | 76.72 | 11.73 |
Leasehold Improvements | - | - | - | - | 205.29 | - |